Molecular recognition of modified adenine nucleotides by the P2Y1-receptor. 2. A computational approach

Journal of Medicinal Chemistry

Volumn 42, Issue 26, 1999, Pages 5338-5347

  Major, Dan T ^a   Halbfinger, Efrat ^a   Fischer, Bilha ^a  

^a BAR ILAN UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE NUCLEOTIDE; ADENOSINE TRIPHOSPHATE; PURINE P2Y RECEPTOR;

ARTICLE; BINDING SITE; DIPOLE; DRUG CONFORMATION; DRUG POTENCY; DRUG RECEPTOR BINDING; LIGAND BINDING; MOLECULAR RECOGNITION; QUANTUM MECHANICS; RECEPTOR AFFINITY; STEREOSPECIFICITY;

EID: 84962360713     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm9901576     Document Type: Article

References (84)

1. (a) Stone, T. W.; Simmonds, H. A. Purines: Basic and Clinical Aspects; Kluwer Academic Publishers: MA, 1991; pp 1-245.
2. (b) Spedding, M.; Williams, M. Development in purine and pyrimidine receptors based therapeutics. Drug Dev. Res. 1996, 39, 436-441.
3. (c) Abbracchio, M. P.; Burnstock, G. Purinergic signaling: Pathophysiological roles. Jpn. J. Pharmacol. 1998, 78, 113-145.
4. (d) Fischer, B. Therapeutic applications of ATP-(P2)-receptors agonists and antagonists. Exp. Opin. Ther. Patents 1999, 9, 385-399.
5. Burnstock, G.; King, B. F. Numbering of cloned P2 purinoceptors. Drug Dev. Res. 1996, 38, 67-71.
6. (a) Erb, L.; Garrad, R.; Wang, Y. J.; Quinn, T.; Turner, J. T.; Weisman, G. A. Site-directed mutagenesis of P2U purinoceptors - positively charged amino acids in transmembrane helix-6 and helix-7 affect agonist potency and specificity. J. Biol. Chem. 1995, 270, 4185-4188.
7. (b) Jiang, Q.; Guo, D.; Lee, B. X.; van Rhee, A. M.; Kim, Y. C.; Nicholas, R. A.; Schachter, J. B.; Harden, T. K.; Jacobson, K. A. A mutational analysis of residues essential for ligand recognition at the human P2Y1 receptor. Mol. Pharmacol. 1997, 52, 499-507.
8. (a) Van Rhee, A. M.; Fischer, B.; van Galen, P. J. M.; Jacobson, K. A. Modelling the P2Y purinoceptor using rhodopsin as template. Drug Des. Discovery 1995, 13, 133-154.
9. (b) Moro, S.; Guo, D.; Camaioni, E.; Boyer, J. L.; Harden, T. K.; Jacobsen, K. A. Human P2Y1 receptor: Molecular modeling and site-directed mutagenesis as tools to identify agonist and antagonist recognition sites. J. Med. Chem. 1998, 41, 1456-1466.
10. (c) Siddiqi, S. M.; Shaver, S. R.; Pendergast, W.; et al. Molecular modeling of the P2Y2 purinoceptor and synthesis of selected ligands. Drug Dev. Res. 1998, 43, 33.
11. (a) Fischer, B.; Boyer, J. L.; Hoyle, C. H. V.; Ziganshin, A. V.; Brizzolara, A. L.; Knight, G. E.; Zimmet, J.; Burnstock, G.; Harden, T. K.; Jacobson, K. A. Identification of potent, selective P2Y-purinoceptor agonists: structure-activity relationships for 2-thioether derivatives of adenosine 5′-triphosphate. J. Med. Chem. 1993, 36, 3937-3946.
12. (b) Burnstock, G.; Fischer, B.; Hoyle, C. H. V.; Maillard, M.; Ziganshin, A. U.; Brizzolara, A. L.; von Isakovics, A.; Boyer, J. L.; Harden, T. K.; Jacobson, K. A. Structure activity relationship for derivatives of adenosine 5′-triphosphate as agonists at P2-purinoceptors: heterogeneity within P2X and P2Y subtypes. Drug Dev. Res. 1994, 31, 206-219.
13. (c) Boyer, J. L.; O'Tuel, J. W.; Fischer, B.; Jacobson, K. A.; Harden, T. K. 2-thioether derivatives of adenine nucleotides are exceptionally potent agonists at adenylyl cyclase-linked P2Y-purinoceptors. Br. J. Pharmacol. 1995, 116, 2611-2616.
14. (d) Zimmet, J.; Järlebark, L.; Hammarberg, T.; van Galen, P. J. M.; Jacobson, K. A.; Heilbronn, E. Synthesis and biological activity of novel 2-thio derivatives of ATP. Nucleosides Nucleotides 1993, 12, 1-20.
15. Fischer, B.; Yefidoff, R.; Major, D. T.; Rutman-Halili, I.; Shneyvays, V.; Zinman, T.; Jacobson, K. A.; Shainberg A. Characterization of 'mini-nucleotides' as P2X-receptor agonists in rat cardiomyocyte cultures. An integrated synthetic, biochemical and theoretical study. J. Med. Chem. 1999, 42, 2685-2696.
16. (a) Scott, S. P.; Tanaka, J. C. Molecular interactions of 3′,5′-cyclic purine analogues with the binding site of retinal rod iod channels. Biochemistry 1995, 34, 2338-2347.
17. (b) Brown, R. L.; Bert, R. J.; Evans, F. E.; Karpen, J. W. Activation of retinal rod cGMP-gated channels: what makes for an effective 8-substituted derivative of cGMP? Biochemistry 1993, 32, 10089-10095.
18. 1-receptor. 1. A synthetic, biochemical, and NMR approach. J. Med. Chem. 1999, 42, 5325-5337.
19. Dewar, M. J. S.; Zoebisch, E. G.; Healy, E. F.; Stewart, J. J. P. AM1: A new general purpose quantum mechanical molecular model. J. Am. Chem. Soc. 1985, 107, 3902-3909.
20. (a) Hall, G. G. The molecular orbital theory of chemical valency VIII. A method for calculating ionisation potentials. Proc. R. Soc. London 1951, A205, 541-552.
21. (b) Roothaan, C. C. J. New developments in molecular orbital theory. Rev. Mod. Phys. 1951, 23, 69-89.
22. (a) Ditchfield, R.; Hehre, W. J.; Pople, J. A. Self-consistent molecular orbital methods. IX. An extended Gaussian-type basis for molecular orbital studies of organic molecules. J. Chem. Phys. 1971, 54, 724-728.
23. (b) Hehre, W. J.; Ditchfield, R.; Pople, J. A. Self-consistent molecular orbital methods. XII. Further extensions of Gaussian type basis sets for use in molecular orbital studies of organic molecules. J. Chem. Phys. 1972, 56, 2257-2261.
24. (c) Hariharan, P. C.; Pople, J. A. Accuracy of AHn equilibrium geometries by single determinant molecular orbital theory. Mol. Phys. 1974, 27, 209-214.
25. (d) Gordon, M. S. The isomers of silacyclopropane. Chem. Phys. Lett. 1980, 76, 163-168.
26. (e) Hariharan, P. C.; Pople, J. A. The influence of polarization functions on molecular orbital hydrogenation energies. Theor. Chem. Acta 1973, 28, 213-222.
27. (f) Francl, M. M.; Pietro, W. J.; Hehre, W. J.; Binkley, J. S.; Gordon, M. S.; DeFrees, D. J.; Pople, J. A. Self-consistent molecular orbital methods. XXIII. A polarization-type basis set for second row elements. J. Chem. Phys. 1982, 77, 3654-3665.
28. (g) Frisch, M. J.; Pople, J. A.; Binkley, J. S. Self-consistent molecular orbital methods. 25. Supplementary functions for Gaussian basis sets. J. Chem. Phys. 1984, 80, 3265-3269.
29. (a) Krishnan, R.; Binkley, J. S.; Seeger, R.; Pople, J. A. Self-consistent molecular orbital methods. XX. A basis set for correlated wave functions. J. Chem. Phys. 1980, 72, 650-654.
30. (b) McLean, A. D.; Chandler, G. S. Contracted Gaussian basis set for molecular calculations. I. Second row atoms, Z=11-18. J. Chem. Phys. 1980, 72, 5639-5648.
31. (c) McGrath, M. P.; Radom, L. Extension of Gaussian-1 (G1) theory to bromine-containing molecules. J. Chem. Phys. 1991, 94, 511-516.
32. (d) Clark, T.; Chandrasekhar, J.; Spitznagel, G. W.; Schleyer, P. v. R. Efficient diffuse function-augment basis set for anion calculations. III. The 3-21+G basis set for first-row elements, Li-F. J. Comput. Chem. 1983, 4, 294-301.
33. (a) Becke, A. D. Density-functional exchange-energy approximation with correct asymptotic behavior. Phys. Rev. A 1988, 38, 3098-3100.
34. (b) Becke, A. D. Density-functional thermochemistry. III. The role of exact exchange. J. Chem. Phys. 1993, 98, 5648-5652.
35. (c) Lee, C.; Yang, W.; Parr, R. G. Development of the Colle-Salvetti correlation-energy formula into a functional of the electron density. Phys. Rev. B 1988, 37, 785-789.
36. Miertus, S.; Scrocco, E.; Tomasi, J. Electrostatic interaction of a solute with a continuum. A direct utilization of ab initio molecular potentials for the prevision of solvent effects. Chem. Phys. 1981, 55, 117-129.
37. (a) Bachs, M.; Luque, F. J.; Orozco, M. Optimization of solute cavities and van der Waals parameters in ab initio MST-SCRF calculations of neutral molecules. J. Comput. Chem. 1994, 15, 446-454.
38. (b) Cossi, M.; Barone, V.; Cammi, R.; Tomasi, J. Ab initio study of solvated molecules: a new implementation of the polarizable continuum model. Chem. Phys. Lett. 1996, 255, 327-335.
39. (a) Cramer, C. J.; Truhlar, D. G. An SCF solvation model for the hydrophobic effect and absolute free energies of aqueous solvation. Science 1992, 256, 213-217.
40. (b) Cramer, C. J.; Truhlar, D. G. AM1-SM2 and PM3-SM3 parametrized SCF solvation models for free energies in aqueous solution. J. Comput.-Aided Mol. Des. 1992, 6, 629-666.
41. (a) Hernández, B.; Orozco, M.; Luque, F. J. Tautomerism of xanthine and alloxanthine: A model for substrate recognition by xanthine oxidase. J. Comput.-Aided Mol. Des. 1996, 10, 535-544.
42. (b) Hernández, B.; Orozco, M.; Luque, F. J. Role of tautomerism of 2-azaadenine and 2-azahypoxanthine in substrate recognition by xanthine oxidase. J. Comput.-Aided Mol. Des. 1997, 11, 153-162.
43. (c) Colominas, C.; Luque, F. J.; Orozco, M. Tautomerism and protonation of guanine and cytosine. Implications in the formation of hydrogen-bonded complexes. J. Am. Chem. Soc. 1996, 118, 6811-6821.
44. Náray-Szabó, G.; Ferenczy, G. G. Chemical Electrostatics. Chem. Rev. 1995, 95, 829-847.
45. Kahn, S. D.; Pau, C. F.; Hehre, W. J. Models for chemical reactivity: Mapping of intermolecular potentials onto electron density surfaces. Int. J. Quantum Chem., Chem. Symp. 1988, 22, 575-591.
46. Murray, J. S.; Brinck, T.; Edward Grice, M.; Politzer, P. Correlations between molecular electrostatic potentials and some experimentally based indices of reactivity. J. Mol. Struct. (THEOCHEM) 1992, 256, 29-45.
47. Frisch, M. J.; Trucks, G. W.; Schlegel, H. B.; Gill, P. M. W.; Johnson, B. G.; Robb, M. A.; Cheeseman, J. R.; Keith, T. A.; Peterson, G. A.; Montgomery, J. A.; Raghavachari, K.; Al-Laham, M. A.; Zakrzewski, V. G.; Ortiz, J. V.; Foresman, J. B.; Cioslowski, J.; Stefanov, B. B.; Nanayakkara, A.; Challacombe, M.; Peng, C. Y.; Ayala, P. Y.; Chen, W.; Wong, M. W.; Andres. J. L.; Replogle, E. S.; Gomperts, R.; Martin, R. L.; Fox, D. J.; Binkley, J. S.; Defrees, D. J.; Baker, J.; Stewart, J. J. P.; Head-Gordon, M.; Gonzales, C.; Pople, J. A. GAUSSIAN 94 (Rev. C), GAUSSIAN 98 (Rev. A.6); GAUSSIAN Inc.: Pittsburgh, PA, 1995, 1998.
48. PC Spartan 1.0, Wavefunction, Inc., Irvine, CA.
49. (a) Ceasar, G. P.; Greene, J. J. Amino-imino tautomerism in the antibiotic formycin A as studied by CNDO/2 molecular orbital theory. J. Med. Chem. 1974, 17, 1122-1124.
50. (b) Orozco, M.; Lluis, C.; Mallol, J.; Canela, E. I.; Franco, R. Theoretical approximation to the reaction mechanism of adenosine deaminase. Quant. Struct.-Act. Relat. 1989, 8, 109-114.
51. (c) Orozco, M.; Luque, F. J. Theoretical study of the tautomerism and protonation of 7-aminopyrazolopyrimidine in the gas phase and in aqueous solution. J. Am. Chem. Soc. 1995, 117, 1378-1386.
52. (d) Orozco, M.; Colominas, C.; Luque, F. J. Theoretical determination of the solvation free energy in water and chloroform of the nucleic acid basis. Chem. Phys. 1996, 209, 19-29.
53. (e) Hotokka, M.; Lønnberg, H. Hydrolysis of adenosine. A semiempirical and ab initio study. J. Mol. Struct. (THEOCHEM) 1996, 363, 191-201.
54. Cramer, C. J.; Truhlar, D. G. Polarization of the nucleic acid bases in aqueous solution. Chem. Phys. Lett. 1992, 198, 74-80.
55. Broo, A.; Holmén, A. Ab initio MP2 and DFT calculations of geometry and solution tautomerism of purine and some purine derivatives. Chem. Phys. 1996, 271, 147-161.
56. (a) Stewart, R. F.; Jensen, L. H. J. Chem. Phys. 1964, 40, 2071.
57. (b) Kistenmacher, T. J.; Rossi, M. A refinement of the crystal structure of 9-Methyladenine. Acta Crystallogr. 1977, B33, 253-256.
58. (c) Brown, R. D.; Godfrey, P. D.; McNaughton, D.; Pierlot, A. P. A study of the major gas-phase tautomer of adenine by microwave spectroscopy. Chem. Phys. Lett. 1989, 156, 61-63.
59. (a) Leszczynski, J. Are the amino groups in the nucleic acid bases coplanar with the molecular rings? Ab initio HF/6-31G* and MP2/6-31G* studies. Int. J. Quantum Chem., Quantum Biol. Symp. 1992, 19, 43-55.
60. (b) Stewart, E. L.; Foley, C. K.; Allinger, N. L.; Bowen, J. P. Ab initio calculations with electron correlation (MP2) on the nucleic acid basis and their methyl derivatives. J. Am. Chem. Soc. 1994, 116, 7282-7286.
61. (c) Šponer, J.; Hobza, P. Nonplanar geometries of DNA bases. Ab initio second-order Møller-Plesset study. J. Phys. Chem. 1994, 98, 3161-3164.
62. (d) Bakalarski, G.; Grochowski, P.; Kwiatkowski, J. S.; Lesyng, B.; Leszczynski, J. Molecular and electrostatic properties of the N-methylated nucleic acid bases by density functional theory. Chem. Phys. 1996, 204, 301-311.
63. (a) McMullan, R. K.; Benci, P.; Craven, B. M. The neutron crystal structure of 9-Methyladenine at 126 K. Acta Crystallogr. 1980, B36, 1424-1430.
64. (b) Craven, B. M.; Benci, P. The charge density and hydrogen bonding in 9-Methyladenine at 126 K. Acta Crystallogr. 1981, B37, 1584-1591.
65. Holmén, A.; Broo, A. A theoretical investigation of the solution N(7)H↔N(9)H tautomerism of adenine. Int. J. Quantum Chem., Quantum Biol. Symp. 1995, 22, 113-122.
66. (a) DeVoe, H.; Tinoco, I., Jr. The stability of helical polynucleotides: Base contributions. J. Mol. Biol. 1962, 4, 500-517.
67. (b) Bergmann, E. D.; Weiler-Feilchenfeld, H.; Neiman, Z. An experimental investigation of the tautomers of adenine. J. Chem. Soc. 1970, B, 1334-1336.
68. The experimental dipole moment values of 9-Me-A and 9-benzyl-A were found to be 3.25 and 2.75 D in dioxane, respectively, by Bergman et al. (ref 30b). However, solvent effects might have been present, as dioxane has been reported to give discrepancies of several tenths of debye (ref 30b). DeVoe et al. (ref 30a) found the dipole moment of 9-n-butyl-A to be 3.0 D in CCl4, and this has been an accepted approximate value for the dipole moment of adenine (ref 33a,b and 34a). Thus, it might be more appropriate to use 3.0 D as the reference value for the dipole moment value of 9-Me-A and adenine in the gas phase, rather than 3.25 D.
69. (a) Wolfenden, R. V. Tautomeric equilibria in inosine and adenosine. J. Mol. Biol. 1969, 40, 307-310.
70. (b) Zamora, F.; Kunsman, M.; Sabat, M.; Lippert, B. Metal-stabilized rare tautomers of nucleobases. 6. Imino tautomer of adenine in a mixed-nucleobase complex of mercury(II). Inorg. Chem. 1997, 36, 1583-1587.
71. (a) Pullman, B.; Berthod, H.; Dreyfus, M. Relatio amine-imine tautomerism in adenines. Theor. Chim. Acta (Berlin) 1969, 15, 265-268.
72. (b) Norinder, U. A theoretical reinvestigation of the nucleic bases adenine, guanine, cytosine, thymine and uracil using AM1. J. Mol. Struct. (THEOCHEM) 1987, 151, 259-269.
73. (c) Katritzky, A. R.; Karelson, M. AM1 calculations of reaction field effects on the tautomeric equilibria of nucleic acid pyrimidine and purine bases and their 1-Methyl analogues. J. Am. Chem. Soc. 1991, 113, 1561-1566.
74. Mely, B.; Pullman, A. Ab initio calculations on cytosine, thymine and adenine. Theor. Chim. Acta (Berlin) 1969, 13, 278-287.
75. Orozco, M.; Hernández, B.; Luque, F. J. Tautomerism of 1-methyl derivatives of uracil, thymine, and 5-bromouracil. Is tautomerism the basis for the mutagenicity of 5-bromouridine? J. Phys. Chem. B. 1998, 102, 5228-5233.
76. (a) Bonnaccorsi, R.; Scrocco, E.; Tomasi, J.; Pullman, A. Ab initio molecular electrostatic potentials. Guanine compared to adenine. Theor. Chim. Acta 1975, 36, 339-344.
77. (b) Alkorta, I.; Perez, J. J. Molecular polarization potential maps of the nucleic acid bases. Int. J. Quantum Chem. 1996, 57, 123-135.
78. (a) Platts, J. A.; Howard, S. T.; Bracke, B. R. F. Directionality of hydrogen bonds to sulfur and oxygen. J. Am. Chem. Soc. 1996, 118, 2726-2733.
79. (b) Salai Cheettu Ammal, S.; Venuvanalingam, P. Ab initio and DFT investigations of lithium/hydrogen bonded complexes of trimethylamine, dimethyl ether and dimethyl sulfide. J. Chem. Soc., Faraday Trans. 1998, 94, 2669-2674.
80. (a) Saenger, W. Principles of Nucleic Acid Structure; Springer-Verlag: New York, 1984; pp 107-110;
81. (b) p 21.
82. (a) Russo, N.; Toscano, M.; Grand, A.; Jolibois, F. Protonation of thymine, cytosine, adenine, and guanine DNA nucleic acid bases: Theoretical investigation into the framework of density functional theory. J. Comput. Chem. 1998, 19, 989-1000.
83. (b) Smets, J.; Houben, L.; Schoone, K.; Maes, G.; Adamowicz, L. Multiple site proton affinities of methylated nucleic acid bases. Chem. Phys. Lett. 1996, 262, 789-796.
84. Kim, K.; Friesner, R. A. Hydrogen bonding between amino acid backbone and side chain analogues: A high level ab initio study. J. Am. Chem. Soc. 1997, 119, 12952-12961.